Tag Archives: Ankylosing Spondylitis Market Forecast

Chronic inflammatory disease ankylosing spondylitis (AS) predominantly impacts the spine, resulting in symptoms including pain, stiffness, and reduced mobility. During the period from 2024 to 2032, the market for ankylosing spondylitis is anticipated to expand at a CAGR of 8.5%. This growth will be driven by developments in biological therapies, a patient-centric approach involving support programs, and raising awareness that ...